{"nct_id":"NCT01610336","title":"A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment","status":"COMPLETED","status_verified_date":"2021-03","start_date":"2012-04-05","start_date_type":"ACTUAL","primary_completion_date":"2016-06-10","primary_completion_date_type":"ACTUAL","completion_date":"2020-05-27","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}